SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (date of earliest event reported): September 6, 1996
(September 6, 1996)
LASERSIGHT INCORPORATED
-----------------------
Exact name of registrant as specified in its charter
Delaware
--------
State or other jurisdiction of incorporation
0-19671 65-0273162
------- ----------
Commission File Number I.R.S. Employer Identification No.
12161 Lackland Road, St. Louis, Missouri 63146
----------------------------------------------
Address of Principal Executive Offices
Registrant's telephone number, including area code: (314) 469-3220
--------------
<PAGE>
Item 5. Other Events.
The press release issued by LaserSight Incorporated dated September 6, 1996 is
incorporated by reference herein.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
(c) Exhibits
Exhibit 99. Press Release dated September 6, 1996
SIGNATURES
----------
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
LaserSight Incorporated
Date: September 6, 1996 By:--------------------------------
Michael R. Farris
Chief Executive Officer
<PAGE>
EXHIBIT 99
NASDAQ SYMBOL: LASE
LASERSIGHT APPOINTS CHIEF OPERATING OFFICER
-------------------------------------------
St.Louis, MO--September 6, 1996...LaserSight Incorporated (NASDAQ:LASE)announced
today the appointment of Richard L. Stensrud to the newly-created position of
chief operating officer.
Michael R. Farris, president and chief executive officer of LaserSight said,
"The appointment of Mr. Stensrud as chief operating officer will provide
operational oversight for all of LaserSight's subsidiaries. This will allow me
to focus a greater portion of my time and attention on the implementation of our
strategic plan. Having spent the last several months establishing sound
operating principles for LaserSight Technologies, I will now be able to direct
more resources toward securing managed care contracts, acquiring practices, and
looking for strategic opportunities as we build a company focused exclusively on
total vision care."
Mr. Stensrud has over 30 years of experience in health care and has been a
director on the LaserSight Board since June 1995. Mr. Stensrud currently
operates a consulting firm serving companies in the health care industry. He has
held senior-level management positions at St. Louis University Medical Center
and, representing his consulting firm, acted as a turnaround executive for
institutions such as Edgewater Hospital in Chicago and St. Catherine's Hospital
in Kenosha, Wisconsin.
At St. Louis University Medical Center, Mr. Stensrud served for over 20 years in
various capacities rising to the rank of chief executive officer. During his
first two years as chief executive of St. Louis University Medical Center, he
turned around several years of annual deficits at the University Hospital. Mr.
Stensrud was an innovator in the development of a system for managing resource
consumption in health care, which systems have been utilized in hospitals
throughout the country. Mr. Stensrud spearheaded the group which acquired
control of a languishing health maintenance organization which grew in
membership to over 100,000 covered lives.
In addition to his continuing service on LaserSight's Board, Mr. Stensrud serves
on the board of directors for Horizon Medical, Inc. of Santa Ana, California;
and ADA Enterprises, Inc. of Northwood, Iowa. He earned his fellowship in the
American College of Health Care Executives and is a member of the Medical Group
Management Association. Mr. Stensrud earned his MBA from George Washington
University in Washington, D.C.
LaserSight Incorporated is a holding company with four operating subsidiaries
engaged in the business of laser manufacturing and international sales,
third-party managed vision care administration, ophthalmic practice management,
and health and vision care consulting services.
For additional information please contact: Marti Benfield
Investor Relations
(314) 469-3220
